GO:0032259 methylation: Biological Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032259 methylation is the biological process in which a methyl group is covalently attached to a molecule, encompassing DNA, RNA, protein, and small-molecule substrates.
• Methylation is catalyzed by methyltransferases that use methyl donors such as S-adenosylmethionine (SAM), and can occur on nitrogen, oxygen, carbon, or sulfur atoms.
• DNA methylation is a stable epigenetic mark that regulates gene expression and is widely studied as a biomarker in cancer, including gastric cancer.
• Protein lysine methylation influences chromatin structure, signaling, and neuronal function, and its dysregulation is linked to neurodegenerative disease.
• RNA methylation is a prevalent modification that affects RNA structure, stability, and translation, with emerging links to disease.
• Environmental methylation, such as microbial mercury methylation, is a critical biogeochemical process with public-health relevance.
Description
Methylation (GO:0032259) is a fundamental biological process defined as the covalent attachment of a methyl group to a molecule. This modification is central to epigenetics, cellular signaling, and metabolism, and it occurs on a wide range of substrates including DNA, RNA, proteins, and small molecules. The discovery of DNA methylation established the concept of an epigenetic layer of information that can be inherited and dynamically regulated. Beyond DNA, methylation of RNA and proteins expands the regulatory repertoire of cells, influencing RNA fate and protein function. The process is also relevant to environmental and microbial biology, where mercury methylation converts inorganic mercury into the neurotoxin methylmercury. Because methylation is involved in gene regulation, development, and disease, it is a major focus of biomedical research, with implications for cancer, neurodegeneration, and infectious disease.
methylation At A Glance
| GO ID | GO:0032259 |
|---|---|
| GO term | methylation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Covalent attachment of a methyl group to a molecule, including DNA, RNA, proteins, and small molecules |
| Methyl donor | S-adenosylmethionine (SAM) is the most common methyl donor |
| Enzymes | Methyltransferases, including DNA methyltransferases, RNA methyltransferases, and protein lysine methyltransferases |
| Substrates | DNA, RNA, proteins, lipids, and small molecules such as mercury |
| Reversibility | Some methylation events are reversible and dynamically regulated |
What Is GO:0032259?
According to the Gene Ontology, methylation (GO:0032259) is the biological process in which a methyl group is covalently attached to a molecule. This definition encompasses the enzymatic transfer of a methyl group from a donor, typically S-adenosylmethionine (SAM), to a variety of acceptor molecules including DNA, RNA, proteins, and small-molecule metabolites. The process is catalyzed by methyltransferases and can target different atoms such as nitrogen, oxygen, carbon, or sulfur, resulting in N-methylation, O-methylation, C-methylation, or S-methylation. Methylation can be reversible and serves diverse functions, from epigenetic gene silencing to detoxification and biosynthesis.
Why Is methylation Important in Cell Biology?
Methylation is essential for normal development and cellular function, and its dysregulation is associated with a broad spectrum of human diseases. DNA methylation patterns serve as biomarkers for cancer diagnosis and prognosis, and they are targets for epigenetic therapies. Protein methylation, particularly on lysine residues, regulates chromatin structure and signaling pathways, and its disruption has been implicated in neurodegenerative disorders. RNA methylation affects RNA stability, splicing, and translation, and its perturbation can impact cell fate and disease progression. Additionally, microbial methylation of mercury generates a potent neurotoxin, highlighting the environmental and public-health importance of this process.
• DNA methylation is a key epigenetic mechanism controlling gene expression and is widely used as a cancer biomarker.
• Protein lysine methylation regulates chromatin and signaling, and its dysfunction is linked to neurodegeneration.
• RNA methylation influences RNA structure, stability, and translation, with emerging roles in disease.
• Methylation is involved in the detoxification and biogeochemical cycling of mercury, producing methylmercury.
• Methyltransferases are potential drug targets for cancer and other diseases.
• Methylation reactions are fundamental to metabolism and biosynthesis.
• Aberrant methylation patterns can serve as diagnostic and prognostic markers.
• Understanding methylation mechanisms aids in the development of epigenetic therapies.
What Happens During methylation?
Methyl donor activation and binding
In simple terms: The cell first prepares and binds the methyl donor, usually SAM, to the enzyme.
Methylation typically begins with the binding of a methyl donor, most commonly S-adenosylmethionine (SAM), to the active site of a methyltransferase. SAM is synthesized from methionine and ATP and serves as the universal methyl group carrier in most biological methylation reactions. The enzyme-substrate complex positions the methyl group for transfer to the acceptor molecule.
Catalytic transfer of the methyl group
In simple terms: The enzyme transfers the methyl group from SAM to the target molecule.
The methyltransferase catalyzes the transfer of the methyl group from SAM to a nucleophilic atom on the substrate, which can be nitrogen, oxygen, carbon, or sulfur. This reaction often involves a transition state where the methyl group is transferred with inversion of configuration or via a radical mechanism, depending on the enzyme class. For example, flavin-dependent RNA methyltransferases use a complex chemistry to methylate RNA.
Substrate specificity and modification
In simple terms: Different enzymes recognize different target molecules, such as DNA, RNA, or proteins.
Methyltransferases exhibit specificity for their substrates, which can include DNA, RNA, proteins, and small molecules. DNA methyltransferases typically methylate cytosine residues in CpG dinucleotides, while RNA methyltransferases modify various RNA species, and protein methyltransferases target lysine or arginine residues. This specificity ensures that methylation occurs at the correct sites and regulates distinct biological processes.
Regulation and reversibility
In simple terms: Methylation can be added and removed, and its levels are tightly controlled.
Methylation is dynamically regulated by the opposing actions of methyltransferases and demethylases. For DNA methylation, the ten-eleven translocation (TET) enzymes can oxidize 5-methylcytosine to promote demethylation. RNA methylation can also be reversed by demethylases such as FTO and ALKBH5, allowing for dynamic control of RNA fate. This reversibility enables cells to respond to environmental and developmental cues.
Functional consequences
In simple terms: Methylation changes how molecules behave, affecting gene expression and protein function.
The addition of a methyl group can alter the physical and chemical properties of the target molecule, influencing its interactions and function. DNA methylation typically represses gene transcription when occurring in promoter regions. Protein methylation can affect protein-protein interactions, stability, and localization, and is involved in epigenetic regulation. RNA methylation affects RNA structure, splicing, export, and translation.
Key Genes Involved in GO:0032259 methylation
The following genes encode enzymes and regulatory proteins that write, erase, or read methylation marks across DNA, RNA, and proteins.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DNMT1 | Maintenance DNA methyltransferase | Epigenetic inheritance and cancer |
| DNMT3A | De novo DNA methyltransferase | Development and leukemia |
| DNMT3B | De novo DNA methyltransferase | Development and cancer |
| TET1 | DNA demethylation enzyme | Epigenetic regulation and cancer |
| TET2 | DNA demethylation enzyme | Clonal hematopoiesis and leukemia |
| METTL3 | RNA m6A methyltransferase | RNA methylation and cancer |
| METTL14 | RNA m6A methyltransferase | RNA methylation and development |
| WTAP | RNA m6A methyltransferase complex subunit | RNA methylation regulation |
| FTO | RNA demethylase | Obesity and cancer |
| ALKBH5 | RNA demethylase | RNA methylation and fertility |
| EZH2 | Histone lysine methyltransferase | Chromatin regulation and cancer |
| SUV39H1 | Histone lysine methyltransferase | Heterochromatin formation |
| SETD7 | Histone lysine methyltransferase | Transcription regulation |
| PRMT1 | Protein arginine methyltransferase | Signaling and cancer |
| CARM1 | Protein arginine methyltransferase | Transcription regulation |
| MTR | Methionine synthase | Methyl donor metabolism |
| MTHFR | Methylenetetrahydrofolate reductase | Folate metabolism and methylation |
How Is methylation Regulated?
Methylation is regulated at multiple levels, including the expression and activity of methyltransferases and demethylases, the availability of methyl donors such as SAM, and the interplay with other epigenetic modifications. For DNA methylation, the balance between DNMTs and TET enzymes determines the dynamic state of 5-methylcytosine. RNA methylation is reversibly controlled by writers (e.g., METTL3/METTL14) and erasers (e.g., FTO, ALKBH5), and can be influenced by cellular stress and signaling pathways. Protein methylation is regulated by the opposing actions of protein methyltransferases and demethylases, and can be modulated by metabolic cues.
methylation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DNMT1 | Cancer, epigenetic silencing | Knockout in cancer cell lines |
| TET2 | Leukemia, clonal hematopoiesis | Point mutation knock-in in hematopoietic cells |
| METTL3 | Cancer, RNA methylation | Overexpression and knockout in tumor models |
| FTO | Obesity, cancer | Knockout and point mutation in cell lines |
| EZH2 | Lymphoma, chromatin regulation | Knock-in of mutant EZH2 |
Cancer
Aberrant DNA methylation is a hallmark of many cancers, including gastric cancer, where it serves as a molecular biomarker for diagnosis and prognosis. Promoter hypermethylation of tumor suppressor genes can lead to their silencing, contributing to tumorigenesis. DNA methyltransferase inhibitors have been developed as epigenetic therapies for certain hematological malignancies.
Neurodegenerative disease
Protein lysine methylation has been implicated in neurodegenerative diseases such as Alzheimer's and Parkinson's, where dysregulation of methylation affects neuronal function and survival. Methylation of proteins involved in neurodegeneration can alter their aggregation and toxicity.
Environmental and metabolic disease
Microbial mercury methylation produces methylmercury, a potent neurotoxin that bioaccumulates in aquatic food chains and poses a risk to human health. Additionally, disruptions in one-carbon metabolism and methyl donor availability can affect global methylation patterns and contribute to disease.
From methylation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of DNMT1 affect global DNA methylation? | DNMT1 knockout cell line |
| How does a TET2 mutation alter 5hmC levels? | TET2 point mutation knock-in |
| What is the effect of METTL3 overexpression on RNA m6A? | METTL3 overexpression cell line |
| Does FTO demethylase activity require specific residues? | FTO point mutation knock-in |
| How does EZH2 methylation of histones affect chromatin? | EZH2 tagged knock-in for ChIP |
| Can CRISPR library screening identify methylation regulators? | Genome-wide CRISPR knockout library |
How to Study the methylation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Bisulfite sequencing | DNA methylation at single-base resolution | Cancer epigenetics |
| MeRIP-seq | RNA m6A methylation transcriptome-wide | RNA methylation studies |
| Mass spectrometry | Protein methylation sites and stoichiometry | Proteomics |
| Methyltransferase assay | Enzyme activity and kinetics | Drug discovery |
| Methylation-specific PCR | Methylation status of specific loci | Biomarker validation |
| ChIP-seq | Histone methylation and chromatin binding | Epigenomics |
| CRISPR screening | Functional roles of methylation genes | Gene discovery |
DNA methylation profiling
Bisulfite sequencing and methylation-specific PCR are standard methods to map DNA methylation at single-base resolution. These techniques are used to identify differentially methylated regions in cancer and other diseases.
RNA methylation detection
MeRIP-seq (m6A-seq) and related methods enable transcriptome-wide mapping of RNA methylation. These approaches have revealed dynamic m6A patterns and their roles in RNA metabolism.
Protein methylation analysis
Mass spectrometry-based proteomics and methylation-specific antibodies are used to detect protein methylation, including lysine and arginine methylation. These methods help identify methylation sites and quantify changes in disease.
Enzyme activity assays
In vitro methyltransferase assays using radioactive or fluorescent SAM analogs measure enzyme kinetics and substrate specificity. Such assays are essential for characterizing methyltransferases and screening inhibitors.
How CRISPR Can Be Used to Study GO:0032259 methylation
Knockout
CRISPR knockout of methyltransferase genes such as DNMT1, METTL3, or EZH2 allows researchers to study loss-of-function phenotypes, including changes in global methylation and gene expression. Knockout cell models are valuable for validating the essentiality of these enzymes in cancer and development.
Point Mutation
Introducing point mutations in catalytic residues of methyltransferases or demethylases (e.g., TET2, FTO) via CRISPR can dissect the enzymatic activity from scaffolding functions. Such models help determine whether specific methylation marks are responsible for observed phenotypes.
Knock-in
Knock-in of tagged versions of methylation enzymes (e.g., GFP or HA tags) enables localization and interaction studies using imaging and immunoprecipitation. Knock-in of disease-associated mutations can model human pathologies in isogenic cell lines.
Overexpression
CRISPR activation or cDNA overexpression of methylation writers or erasers can test gain-of-function effects on cellular methylation and behavior. Overexpression models are useful for studying oncogenic roles of methyltransferases.
How EDITGENE Supports methylation Research
Researchers studying methylation-related genes often need to determine whether a candidate gene is causally involved in a specific methylation event or disease phenotype. EDITGENE provides a comprehensive suite of CRISPR-based services to create precisely engineered cell models for functional studies of methylation.
Contact EDITGENE today to design your custom CRISPR model for methylation research.
Frequently Asked Questions About methylation
What is methylation (GO:0032259)?
Methylation is the biological process in which a methyl group is covalently attached to a molecule, such as DNA, RNA, proteins, or small molecules.
What genes are involved in methylation?
Key genes include DNA methyltransferases (DNMT1, DNMT3A, DNMT3B), RNA methyltransferases (METTL3, METTL14), histone methyltransferases (EZH2, SUV39H1), and demethylases (TET1, TET2, FTO, ALKBH5).
How does DNA methylation regulate gene expression?
DNA methylation in promoter regions typically represses transcription by preventing transcription factor binding or recruiting methyl-CpG-binding proteins.
What is the role of methylation in cancer?
Aberrant DNA methylation can silence tumor suppressor genes and is used as a biomarker for cancer diagnosis and prognosis.
What is RNA methylation?
RNA methylation is the addition of methyl groups to RNA molecules, affecting their structure, stability, and translation.
What is protein lysine methylation?
Protein lysine methylation is the methylation of lysine residues on proteins, regulating chromatin structure and signaling, and is linked to neurodegeneration.
How can I study methylation in the lab?
Common methods include bisulfite sequencing for DNA, MeRIP-seq for RNA, mass spectrometry for proteins, and methyltransferase activity assays.
What is the difference between methylation and demethylation?
Methylation adds a methyl group, while demethylation removes it; both are dynamically regulated by opposing enzymes.
Can CRISPR be used to study methylation?
Yes, CRISPR knockout, knock-in, and point mutation models are widely used to study the function of methylation-related genes.
What is mercury methylation?
Mercury methylation is the microbial conversion of inorganic mercury to methylmercury, a neurotoxin that bioaccumulates in aquatic environments.
Conclusion
Methylation (GO:0032259) is a ubiquitous and essential biological process that modifies DNA, RNA, proteins, and small molecules, with profound impacts on gene regulation, development, and disease. Its dysregulation is implicated in cancer, neurodegeneration, and environmental toxicity, making it a critical area of biomedical research. Advances in CRISPR-based models and sequencing technologies continue to unravel the complexities of methylation, offering new opportunities for therapeutic intervention.
References
- 1. Rowe EM et al.. 2019. Lysine methylation: Implications in neurodegenerative disease.. Brain Res 1707:164-171 PMID: 30465751
- 2. Song H et al.. 2020. Enzymatic methylation of the amide bond.. Curr Opin Struct Biol 65:79-88 PMID: 32653730
- 3. Tompkins JD. 2022. Discovering DNA Methylation, the History and Future of the Writing on DNA.. J Hist Biol 55(4):865-887 PMID: 36239862
- 4. Tahara T et al.. 2015. DNA methylation as a molecular biomarker in gastric cancer.. Epigenomics 7(3):475-86 PMID: 26077432
- 5. Regnell O et al.. 2019. Microbial Mercury Methylation in Aquatic Environments: A Critical Review of Published Field and Laboratory Studies.. Environ Sci Technol 53(1):4-19 PMID: 30525497
- 6. Akgül B et al.. 2026. Linking RNA methylation to structure: a biophysical perspective.. FEBS J 293(10):2799-2810 PMID: 41506654
- 7. Feng K et al.. 2020. Late-stage oxidative C(sp(3))-H methylation.. Nature 580(7805):621-627 PMID: 32179876
- 8. Hamdane D et al.. 2016. Flavin-Dependent Methylation of RNAs: Complex Chemistry for a Simple Modification.. J Mol Biol 428(24 Pt B):4867-4881 PMID: 27825927
